FXN and Friedreich ataxia: In FA, in vitro SFN treatment partially rescues the cellular phenotypic defects in frataxin-silenced motor neuron-like cells [92], in neural stem cells isolated from the KIKO FA mouse model [10] and in FA fibroblasts [77].